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2,3,7,8-Tetrachlorodibenzo-p-dioxin
(dioxin, TCDD) is a persistent environmen-
tal contaminant, a human and rodent car-
cinogen, and the most potent ligand for
the aryl hydrocarbon receptor gene (AhR)
(Fingerhut et al. 1991; Gu et al. 2000;
Kociba et al. 1978; McGregor et al. 1998).
The AhR gene also displays afﬁnity for struc-
turally related xenobiotics, including poly-
chlorinated dibenzo-p-dioxins (PCDDs),
polychlorinated dibenzofurans (PCDFs),
and coplanar polychlorinated biphenyls
(PCBs) (Denison et al. 2002). Ligand bind-
ing and activation of AhR induces nuclear
localization and heterodimerization with the
AhR nuclear transporter (ARNT) protein
(Whitlock 1999). This activated heterodimer
binds to cognate cis-acting sequences [dioxin
response elements (DREs)], located in the
5´-regulatory region of target genes.
A specific subgroup of genes are acti-
vated by an AhR-dependent mechanism
during dioxin exposure, including (but not
limited to) cytochrome P450 (CYP)1A1
CYP1A1, CYP1A2, CYP1B1, aldehyde
dehydrogenase (ADH), NADPH-quinone-
oxidoreductase (NQO1), glutathione
S-transferase (GST) Ya (GSTA1), and
UDP-glucuronosyltransferase 1A1 (UGT1A1)
(Manjunath and Dufresne 1988; Mimura and
Fujii-Kuriyama 2003; Schrenk 1998; Sutter
and Greenlee 1992). AhR-dependent tran-
scription is required for dioxin toxicity
(Bunger et al. 2003), but it is unclear how
activation of AhR-dependent genes produces
the multiplicity of toxic responses characteris-
tic of dioxin exposure.
As an attempt to characterize AhR-
dependent genes and signaling pathways
responsible for subchronic dioxin toxicity,
the present study evaluated differential
hepatic gene expression in female Harlan
Sprague-Dawley (SD) rats exposed sub-
chronically (13 weeks) to toxicologically
equivalent doses of the AhR ligands TCDD
(100 ng/kg/day), 2,3,4,7,8-pentachloro-
dibenzofuran (PeCDF; 200 ng/kg/day),
3,3´,4,4´,5-pentachlorobiphenyl (PCB126;
1,000 ng/kg/day), or the non-AhR ligand
2,2´,4,4´,5,5´-hexachlorobiphenyl
(PCB153; 1,000 µg/kg/day). This gene
expression study was performed in con-
junction with a cancer bioassay conducted
by the National Toxicology Program
(NTP), which included interim sacrifices
(13, 30, and 52 weeks) to investigate tissue
dosimetry, histopathology, and other
biochemical and molecular responses
throughout the 2-year study.
Subchronic TCDD exposure is associ-
ated with numerous toxic responses, and
many of these responses may be AhR
dependent. Kociba et al. (1976) showed
previously that SD rats exposed to high lev-
els of TCDD (1 µg/kg/day) for 13 weeks
were subject to mortality, chloracne, thymic
atrophy, and a “wasting syndrome” charac-
terized by rapid weight loss and fat redistri-
bution. Antioxidant enzyme expression was
enhanced in rats exposed to lower doses of
TCDD for 13 weeks (10–46 ng/kg/day;
Hassoun et al. 2003), and the hepatotoxic
biomarkers serum bilirubin and alkaline
phosphatase were elevated in rats exposed to
intermediate doses for the same exposure
period (100 ng/kg/day TCDD; Kociba
et al. 1976). Rats exposed to TCDD for
13 weeks (100 ng/kg/day) also developed
cachexia, hepatic hypertrophy, and altered
hepatic foci (Kociba et al. 1976), whereas
chronic exposure (104 weeks) at this dose
resulted in porphyria and cancer of the
liver, lung, and oral mucosa (Kociba et al.
1978; NTP 2004a). Although AhR activa-
tion likely contributes to the many toxico-
logic effects produced by subchronic and
chronic TCDD exposures, little is known
about AhR and non-AhR signaling mecha-
nisms mediating these effects.
The TCDD, PeCDF, and PCB126
exposure doses used in this study were
carcinogenic to female SD rats, but tumors
and other hepatotoxic effects were not
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We employed DNA microarray to identify unique hepatic gene expression patterns associated with
subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other halogenated aro-
matic hydrocarbons (HAHs). Female Harlan Sprague-Dawley rats were exposed for 13 weeks to
toxicologically equivalent doses of four different HAHs based on the toxic equivalency factor of
each chemical: TCDD (100 ng/kg/day), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF;
200 ng/kg/day), 3,3´,4,4´,5-pentachlorobiphenyl (PCB126; 1,000 ng/kg/day), or 2,2´,4,4´,5,5´-
hexachlorobiphenyl (PCB153; 1,000 µg/kg/day). Global gene expression proﬁles for each expo-
sure, which account for 8,799 gene probe sets contained on Affymetrix RGU34A GeneChips, were
compared by principal components analysis. The aryl hydrocarbon receptor (AhR) ligands TCDD,
PeCDF, and PCB126 produced very similar global gene expression proﬁles that were unique from
the nonAhR ligand PCB153, underscoring the extensive impact of AhR activation and/or the
resulting hepatic injury on global gene expression in female rat liver. Many genes were co-
expressed during the 13-week TCDD, PeCDF, or PCB126 exposures, including classical
AhR-regulated genes and some genes not previously characterized as being AhR regulated, such as
carcinoembryonic-cell adhesion molecule 4 (C-CAM4) and adenylate cyclase-associated protein 2
(CAP2). Real-time reverse-transcriptase polymerase chain reaction conﬁrmed the increased expres-
sion of these genes in TCDD-, PeCDF-, and PCB126-exposed rats as well as the up- or down-
regulation of several other novel dioxin-responsive genes. In summary, DNA microarray
successfully identiﬁed dioxin-responsive genes expressed after exposure to AhR ligands (TCDD,
PeCDF, PCB126) but not after exposure to the non-AhR ligand PCB153. Together, these ﬁnd-
ings may help to elucidate some of the fundamental features of dioxin toxicity and may further
clarify the biologic role of the AhR signaling pathway. Key words: AhR, HAH, liver, microarray,
PCB, TCDD. Environ Health Perspect 112:1636–1644 (2004). doi:10.1289/txg.7253 available
via http://dx.doi.org/ [Online 22 September 2004]evident until several months after the
13-week interim sacrifice (NTP 2004a,
2004b, 2004c). Thus, evaluation of differ-
ential gene expression patterns after
13-week exposures to subchronic halo-
genated aromatic hydrocarbons (HAHs)
may yield important clues about the mech-
anisms by which these chemicals produce
their chronic toxicologic effects, including
cancer. Although there have been several
attempts to evaluate TCDD-dependent
gene expression in vitro and in vivo (Fisher
et al. 2004; Frueh et al. 2001; Martinez
et al. 2002; Puga et al. 2000), to our
knowledge, this is the ﬁrst of such to char-
acterize gene expression during long-term,
subchronic exposure to carcinogenic doses
of TCDD and other dioxin-like chemicals.
Materials and Methods
Sample Procurement
Tissues for this study were provided by the
NTP (2004a, 2004b, 2004c) as part of a
2-year bioassay for relative carcinogenic
potencies of dioxin-like chemicals. Female
Harlan SD rats were exposed 5 days a week
by oral gavage to toxicologically equivalent
doses of TCDD [toxic equivalency factor
(TEF) = 1.0; 3, 10, 22, 46, 100 ng/kg/day],
PeCDF (TEF = 0.5; 6, 20, 44, 92,
200 ng/kg/day), PCB126 (TEF = 0.1; 10,
30, 100, 175, 300, 550, 1,000 ng/kg/day),
PCB153 (TEF = 0, N/A; 10, 100, 300,
1,000 µg/kg/day), or corn oil:acetone
(99:1; vehicle control). Toxicologic dose
equivalence was based on the current
World Health Organization TEF recom-
mendations (Van den Berg et al. 1998).
Subgroups of rats were sacriﬁced at 14, 31,
and 53 weeks (corresponding to 13, 30, or
52 weeks of exposure), and target organs
were removed, ﬂash frozen in liquid nitro-
gen, and stored at –70°C for mechanistic
studies.
RNA Isolation and Hybridization
The present study used liver from female
rats exposed to vehicle control or the high-
est dose of each compound for 13 weeks to
ensure that hepatic gene expression was
evaluated in the context of carcinogenic
exposure doses for TCDD, PeCDF, and
PCB126. Frozen hepatic tissue was dis-
rupted by homogenization with a rotor sta-
tor homogenizer, and total RNA was
isolated with Qiagen RNeasy columns
Qiagen Inc., Valencia, CA). There were a
total of six rats in each exposure group.
Three pools of RNA were created from
each exposure group (n = 2 rats per pool),
similar to the experimental design of
Yechoor et al. (2002). Pooled total RNA
was further purified using the Qiagen
poly(A) RNA isolation kit. RNA integrity
was assessed by the Agilent Bioanalyzer
2100 (Agilent Technologies, Palo Alto,
CA). This study employed high-quality
RNA that displayed two distinct, sharp
peaks and a 28S/18S ribosomal RNA ratio
greater than 1. Poly(A) RNA was trans-
formed into labeled cRNA by the Roswell
Park Cancer Institute Microarray and
Genomics Core Facility (Buffalo, NY).
cRNA from each pool was fragmented and
its quality evaluated with Affymetrix
GeneChip Test3 arrays (Santa Clara, CA)
by comparing 3´:5´ signal ratios of house-
keeping genes. High-quality cRNA (3´:5´
signal ratio near 1) was subsequently
hybridized to Affymetrix RGU34A
GeneChips, and chips were scanned with
the Affymetrix 428 scanner.
Data Analysis
Cell intensity ﬁles (.CEL) ﬁles were gener-
ated with Affymetrix Microarray Suite
(MAS) 5.0 software (Affymetrix) and
probe-level data were background sub-
tracted and normalized, and gene expres-
sion was summarized using the MAS 5.0
algorithm included in the Bioconductor
Affy package for R, version 1.6.1 (Ihaka
and Gentleman 1996). Gene expression
data from n = 3 GeneChips in each expo-
sure group were averaged, and changes in
gene expression were calculated as the aver-
age change versus gene expression for the
n = 3 GeneChips from the vehicle-treated
control group. Cluster analysis was per-
formed with TIGR Microarray Experiment
Viewer (Saeed et al. 2003). The gene
expression proﬁles associated with TCDD,
PeCDF, PCB126, and PCB153 exposures
were assessed by principal components
analysis (PCA) with the covariance value
distance metric (Raychaudhuri et al. 2000)
to evaluate relationships between exposure
groups. Genes co-expressed during various
exposure conditions were identified by
Pavlidis template matching (PTM; Pavlidis
and Noble 2001). For each PTM analysis,
gene expression proﬁle templates were con-
structed by designating relative gene expres-
sion ratios for each exposure condition.
Gene expression data were ﬁltered for genes
that matched each template based on the
Pearson correlation (R ≥ 0.9). Template
matching genes were subjected to Euclidean
distance hierarchical clustering. Genes were
annotated with GenBank accession num-
bers by Affymetrix MAS 5.0 and TIGR
Resourcerer gene annotation tool (Tsai
et al. 2001), and official gene names were
provided by the Rat Genome Database
(http://rgd.mcw.edu/). Expressed sequence
tags without annotation were ﬁltered from
PTM outputs, thus restricting gene sets to
annotated genes. Promoters of selected
genes were mapped for DREs using
MatInspector Professional (Quant et al.
1995). Quantitative gene expression esti-
mates obtained by microarray analysis were
validated by two-step real-time reverse-tran-
scriptase polymerase chain reaction (RT-
PCR) for selected genes.
Real-Time RT-PCR Validation of
Gene Expression
Reverse transcriptase reactions (80 µL) con-
tained 20 µg total RNA, 0.5 mM dNTP
mix, and 15 ng/µL random primers, 1×
first-strand buffer, 10 mM dithiothreitol,
27 U Rnasin RNase inhibitor (Promega,
Madison, WI), and 800 U superscript
reverse transcriptase (Invitrogen). A mixture
containing total RNA, dNTPs, and random
primers was heated to 65°C for 5 min to
denature the RNA and then immediately
placed on ice. The remaining components
of the reaction mixture were then added to
the RNA, and cDNA synthesis was per-
formed at 42°C for 60 min. Reactions were
terminated by heating to 70°C for 10 min.
PCR primers were selected from
GenBank database sequences with Primer3
software (Rozen and Skaletsky 2000).
Primer sequences were between 20 and
22 bp, contained at least one 3´-GC clamp,
displayed a maximal Tm (melting tempera-
ture) difference of 1°C, a maximal poly-X
value of 3, maximal 3´-complementarity of
2, and a Tm between 60 and 62°C.
Nonspeciﬁc mispriming was managed by a
mispriming threshold of 10.0 in the rodent
mispriming library. The primer sequences
used in the present study are shown in
Table 1.
Real-time PCR was performed with the
SYBR Green PCR kit from Applied
Biosystems (Foster City, CA) according to
the manufacturer’s instructions. PCR reac-
tions (25 µL) contained diluted cDNA,
1× SYBR Green buffer, 3 mM MgCl2,
0.2 mM dNTP mix, 0.2 µM left and right
primers, 10 nM fluorescein, and 1.1 U of
Amplitaq Gold polymerase. The reaction
was initiated by incubation at 95°C for
10 min and followed by 40 cycles of denat-
uration at 95°C for 15 sec and primer
annealing/extension at 60°C for 1 min.
Sample fluorescence was evaluated during
the annealing/extension step. Upon com-
pletion of thermocycling, the speciﬁcity of
each reaction was evaluated by melting
analysis. Samples were heated to 95°C for
2 min and cooled to 55°C. The tempera-
ture was maintained at 55°C for 15 sec to
analyze sample fluorescence, and the tem-
perature was increased by increments of
0.5°C followed by 15 sec of fluorescence
analysis for a total of 80 cycles.
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validated over a range of cDNA concen-
trations. Primer pairs that demonstrated
reaction efﬁciencies between 85 and 103%,
concentration vs. ﬂuorescence slope factors
between –1.3 and –1.7, and concentration
versus fluorescence correlation coefficients
between 0.98 and 1.0 were accepted for fur-
ther use. After primer validation, PCR reac-
tions were performed with a single cDNA
concentration, and the threshold cycle (Ct)
was determined for each reaction. The dif-
ference (∆Ct) between the threshold cycle
for the target gene and endogenous control
gene (18S RNA) was calculated for each
sample, and the 18S normalized relative
expression of each gene was calculated by
the comparative method according to the
Applied Biosystems’ User Bulletin No. 2 for
the ABI Prism Sequence Detection System
(Applied Biosystems), as described by
Imasato et al. (2002).
Results
Dosimetry and Liver Pathology 
from the NTP Cancer Bioassay
Tissue dosimetry and liver pathology for
each 13-week HAH exposure are detailed in
Table 2. The dosimetry values indicate that
the AhR ligands (TCDD, PeCDF, PCB126)
exhibit more pronounced hepatic accumula-
tion, relative to administered dose, than does
the non-AhR ligand PCB153. It is impor-
tant to note that the exposure to PCB153 is
in micrograms per kilogram per day
(µg/kg/day), whereas the level of PCB153 in
the liver is in units of nanograms per gram of
liver (ng/g liver), supporting the greatly
reduced relative hepatic accumulation of
PCB153. Preferential hepatic accumulation
of TCDD, PeCDF, and PCB126 is consis-
tent with CYP1A2 serving as a sequestering
protein for AhR ligands (Van den Berg et al.
1994). There was a statistically significant
increase in the incidence of hepatic hypertro-
phy for all exposures compared with the
respective vehicle control animals. Liver
hypertrophy was mild to moderate among
female rats from the TCDD exposure group,
minimal to mild in the PCB126 exposure
group, and minimal in rats exposed to
PeCDF or PCB153. A limited and non-
significant number of animals exposed to
TCDD for 13 weeks displayed multinucle-
ated hepatocytes.
There was an increased incidence and
severity of liver hypertrophy for the TCDD
and PCB126 exposures relative to the other
AhR ligand, PeCDF. PTM was employed to
identify genes associated with the more pro-
nounced hepatic hypertrophy in the TCDD
and PCB126 groups relative to the PeCDF
group (Figure 1). We were unable to iden-
tify genes that were selectively repressed, but
we did identify a limited subset of genes
selectively induced by TCDD and PCB126
compared with PeCDF. These genes were
functionally classified as neurotransmitter
and endocrine signaling genes.
Effects of HAH Exposure on Global
Hepatic Gene Expression
TCDD, PeCDF, and PCB126 activate
AhR, whereas PCB153 displays little or
no binding affinity for AhR. PCA was
employed to determine whether the rela-
tionship between global gene expression
proﬁles for each chemical would be related
to their AhR afﬁnities (Figure 2). The prin-
cipal components for TCDD, PeCDF, and
PCB126 exposures were spatially co-local-
ized along the x-axis of the PCA plot
(PeCDF and PCB126 were localized to the
same quadrant, whereas TCDD was proxi-
mally located in the adjacent quadrant).
The principal component for the PCB153
exposure was unique from those of AhR
ligands.
Because the global gene expression
profile associated with PCB153 exposure
differed from that of TCDD, PeCDF, and
PCB126, PTM was employed to identify
genes that were selectively induced or
repressed by PCB153 (Figure 3). PCB153
does not bind to AhR, and genes activated
or repressed during PCB153 exposure are
likely regulated by an AhR-independent
mechanism. Liver from PCB153-exposed
rats exhibited a unique class of differen-
tially expressed genes compared with rats
exposed to AhR ligands, with CYP2B1
being the most up-regulated by PCB153.
PCB153 exposure also produced the differ-
ential expression of proinﬂammatory genes
interleukin 2 (IL2) and interleukin 1 (IL1)
and myxovirus (influenza virus) resistance
(MX1) and apoptosis-related genes B-cell
leukemia/lymphoma 2 (BCL-2) and Wee1
tyrasine kinase (WEE1).
Global hepatic gene expression proﬁles
of animals exposed to PeCDF more closely
resembled those of PCB126-exposed ani-
mals than of TCDD-exposed animals,
indicating that PeCDF and PCB126 may
co-regulate a unique group of genes that
are not differentially expressed relative to
TCDD exposure. This subgroup of genes
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Table 1. Primer sequences for real-time RT-PCR.
GenBank accession no.a Gene Primer sequences (5’ to 3’)
U09540 CYP1B1 CGTCTGATGCTTTCAGCAAAGG
GCAGGCTTTCCAACTAAGCCAG
U23055 C-CAM4 CTCGTCTCCTCAGAGGGCAGATTC
ACAGCGTCTACGGTGACTTGGG
Al145367 CAP2 ATCACCGTCGATAACTGCAAG
CCCATTACCTGGATCTGAATG
U46118 CYP3A9 CCACCAGCATGAAAGACATC
GTCCTGTGGGTTGTTAAGGG
M63991 SERPIN7A TCTGGCTCTAGCACCCAAAC
GATCAAATGCTGGAAGCCC
M25890 SST CAGAACTGCTGTCTGAGCCC
AGCTCCAGCCTCATCTCGTC
X65296 CES3 GGCCATTTCTGAGAGTGGTGTG
GCAGGCAATGAACCATAACAGC
V01270 Ribosomal 18S RNA GAGCGAAAGCATTTGCCAAG
GGCATCGTTTATGGTCGGAA
aFrom GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db_nucleotide)
Table 2. Summary of the 13-week dosimetry and liver pathology data from the NTP cancer bioassay.a
TCDD PeCDF PCB126 PCB153
Control 100 ng/kg/day Control 200 ng/kg/day Control 1,000 ng/kg/day Control 1,000 µg/kg/day
Liver levels (ng/g) BLOQ 18.3 ± 0.8 BLOQ 132.9 ± 47.4 BLOQ 412.6 ± 73.5 BLOQ 9,250 ± 2,061
Liver hypertrophy 1 (1.0) 10* (2.3) 0 7* (1.0) 0 10* (1.7) 0 9* (1.2)
Multinucleated hepatocytes 0 3 (1.0) 0 0 0 0 0 0
Diffuse fatty change 0 2 (1.0) 0 2 (1.0) 0 0 0 0
Pigmentation 0 0 0 2 (1.0) 0 0 0 0
Abbreviations: BLOQ, below level of quantiﬁcation; N/A, not applicable.
aDosimetry values are the mean ± SD of 10 rats per group. Values for each pathologic end point represent the incidence or number of rats (of 10) that exhibit the response. The mean
severity score is given in parentheses (1, minimal; 2, mild; 3, moderate; 4, marked). *Statistically signiﬁcant (p < 0.05) increase in the incidence of a given pathologic response relative to
the respective control group.may be activated by an AhR-independent
mechanism unique to PeCDF and
PCB126. PTM was used to identify genes
that were selectively activated by PeCDF
and PCB126 compared with TCDD
(Figure 4). A total of 29 different genes
were identiﬁed, all of which were mutually
induced by PeCDF and PCB126. These
genes included those coding for metabolic
enzymes (cytochrome P450 15-beta gene,
CYP2C39, NADH dehydrogenase) and
oxidative stress response genes [catalase
(CAT), cytochrome c oxidase (COX)].
PTM was also employed to identify
genes co-expressed during TCDD, PeCDF,
and PCB126 exposures because differential
expression of these genes may be associated
with AhR-mediated pathology (Figure 5).
Many of the TCDD-inducible genes identi-
fied by PTM represented classic dioxin-
inducible genes, including CYP1A1,
CYP1B1, CYP1A2, NAD(P)H-menadione
oxidoreductase, immunoglobulin M, and
UDP glycosyltransferase 1 family, polypep-
tide A1. Although cytochrome c oxidase has
been associated with TCDD induction,
COX8H represents a novel dioxin-inducible
isoform of this gene. Carcinoembryonic-cell
adhesion molecule 4 (C-CAM4) and adeny-
late cyclase–associated protein 2 (CAP2)
were also induced during TCDD, PeCDF,
and PCB126 exposures. Several genes were
coordinately down-regulated by TCDD,
PeCDF, and PCB126 but not by PCB153,
including epidermal growth factor and
mitochondrial thioesterase.
C-CAM4 and  CAP2 were highly
induced by all three AhR ligands but have
not been linked to AhR-mediated transcrip-
tional regulation. The enhanced expression
of C-CAM4 and CAP2 was veriﬁed by real-
time RT-PCR (Table 3). To determine
whether C-CAM4 and CAP2 are direct AhR
target genes, the 5´-regulatory sequences of
these genes were modeled by MatInspector
Professional to identify potential cis-acting
DRE sequences within these gene promot-
ers. Neither gene promoter contained DRE
consensus sequences.
The expression of several additional
genes was also verified by real-time RT-
PCR (Table 3). In general, there was rela-
tively good association between the up- or
down-regulation of genes according to
Affymetrix GeneChip analysis and real-time
RT-PCR methods. CYP1B1, C-CAM4, and
CAP2 were consistently increased in livers
of rats exposed to AhR ligands (TCDD,
PeCDF, PCB126), whereas livers of
PCB153-exposed rats exhibited little or no
change. CYP3A9 and serine proteinase
inhibitor, clade A (SERPIN7A) were down-
regulated by exposure to AhR ligands,
whereas somatostatin was down-regulated
by exposure to AhR ligands and PCB153.
Real-time RT-PCR also suggests that car-
boxylesterase 3 (CES3) was down-regulated
by AhR ligands.
Discussion
The TEF classiﬁcation scheme has been used
for many years to facilitate risk assessment
for individual congeners and mixtures of
dioxin-like PCDDs, PCDFs, and PCBs
(Becher et al. 1998; Finley et al. 2003;
Flesch-Janys et al. 1998; Van den Berg et al.
1998). However, there is some question
about whether TEF values are predictive of
long-term toxicologic end points, including
cancer (Safe 1994). The present study eval-
uated hepatic gene expression during a
13-week interim sacrifice from a 2-year
chronic toxicity and carcinogenicity study
of TCDD, PeCDF, PCB126, and PCB153
in female Harlan SD rats. The TCDD,
PeCDF, and PCB126 exposures from this
study produced cholangiocarcinoma, hepa-
tocellular adenoma, toxic hepatopathy,
multinucleated hepatocytes, diffuse fatty
change, and liver pigmentation after 2 years
of exposure (NTP 2004a, 2004b, 2004c).
Liver tumor incidence was not equivalent
among AhR ligands but instead was higher
in animals exposed to TCDD and PCB126
compared with animals exposed to PeCDF
at toxicologically equivalent doses. Similar
results were seen for the incidence and
severity of hepatic hypertrophy at 13 weeks,
where PeCDF produced less hypertrophy
than TCDD and PCB126 (Table 2). The
13-week PeCDF exposure also induced
substantially less CYP1B1 mRNA com-
pared with TCDD and PCB126, as shown
by RT-PCR (Table 3). Thus, it is possible
that enhanced AhR activation by TCDD
and PCB126 may be responsible for the
increased liver pathology of TCDD- and
PCB126-exposed rats compared with
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Figure 1. Hepatic genes differentially expressed during TCDD and PCB126 exposures but not during PeCDF
exposure. Acc. no., GenBank accession number. PTM was used to identify genes co-expressed after expo-
sure to TCDD and PCB126 but not PeCDF for 13 weeks. Matching genes conformed to a template where the
relative expression ratios for toxicant versus vehicle exposure were PeCDF = 0.2, TCDD = 1, and PCB126 = 1
(r2 = 0.9). The PTM output was further reﬁned to include only those genes differentially expressed ≥ 2-fold
in livers of rats exposed to TCDD and PCB126 compared with vehicle control animals. (A) PTM diagram
showing co-expressed genes. The color key indicates the magnitude of change. (B) Average fold changes
for n = 3 Affymetrix GeneChips (each chip represents pooled RNA from two animals). Accession numbers
and gene names are from GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide).
A B
PCB 153
TCDD
PCB126
PeCDF
Z X
Y
Figure 2. Relationship between global hepatic gene
expressions resulting from TCDD, PeCDF, PCB126,
or PCB153 exposures. The global hepatic gene
expression proﬁles for rats exposed to each toxi-
cant were analyzed by PCA. The principal compo-
nents (X, Y, Z) for the gene expression of rats
exposed to AhR ligands TCDD, PeCDF, and PCB126
were localized near a single PCA quadrant,
whereas the principal component for the nonAhR
ligand PCB153 was located in a distant quadrant.PeCDF-exposed rats. Consistent with these
ﬁndings, our laboratory previously reported
more CYP1-mediated ethoxyresorufin-O-
deethylase activity in liver microsomes from
TCDD- and PCB126-exposed female SD
rats compared with PeCDF-exposed rats
after 13 weeks of exposure (Shubert et al.
2002). Thus, the 200 ng/kg/day PeCDF
exposure is less effective in activating AhR-
dependent gene expression and less toxic
regarding hepatic hypertrophy and carcino-
genicity compared with 100 ng/kg/day
TCDD and 1,000 ng/kg/day PCB126
exposures.
An alternative possibility of the
enhanced toxicity of TCDD and PCB126
exposures compared with PeCDF is that
these chemicals activate a unique subgroup
of genes that is not activated by PeCDF,
thus enhancing toxicity. In support of this
possibility, DNA microarray analysis
revealed a subset of differentially expressed
genes in TCDD- and PCB126-exposed
rat liver that were relatively unchanged dur-
ing PeCDF exposure (Figure 1). These
genes were functionally related to neuro-
transmitter and neuroendocrine signaling.
Activation of neuroendocrine signaling by
TCDD has been demonstrated in other tis-
sues, including monkey hypothalamus and
rodent pituitary and adrenal (Pitt et al.
2000; Shridhar et al. 2001). Subchronic
exposure to TCDD and PCB126 may
therefore stimulate hepatic neuroendocrine
signaling. Activation of hepatic neuroen-
docrine cells by these chemicals may also be
a symptom or contributor to chemical-
induced liver hypertrophy, which was sub-
stantially less in PeCDF-exposed rats.
AhR activation by PCDDs, PCDFs, and
coplanar PCBs is a hallmark of exposure to
dioxin-like chemicals and is likely impli-
cated in their toxicity. AhR activation has
also been attributed to the direct activation
of some dioxin-responsive genes (Mimura
and Fujii-Kuriyama 2003; Schrenk 1998;
Sutter and Greenlee 1992). However, there
is little knowledge regarding how many
genes are activated or repressed in an
AhR-dependent mechanism during sub-
chronic exposure to AhR ligands. The pre-
sent study used PCA to address relationships
between exposure to traditional AhR ligands
(TCDD, PeCDF, and PCB126) and the
non-AhR ligand PCB153. PCA has been
previously employed to compare genomic
profiles of toxicants (Heijne et al. 2003),
identify common molecular effects among
potential drug candidates (Shi et al. 2000),
and predict treatment prognosis (Ringberg
et al. 2001). PCA revealed a unique associa-
tion among hepatic gene expression proﬁles
produced by exposure to dioxin-like toxi-
cants, where global gene expression proﬁles
for rats exposed to PeCDF and PCB126
were very similar and closely related to the
gene expression proﬁle for TCDD exposure
(Figure 2). The global gene expression pro-
file for exposure to the noncoplanar
PCB153, however, was substantially differ-
ent from that of the dioxin-like AhR lig-
ands. Prominent differences between
PCB153-mediated and AhR-ligand–medi-
ated gene expression suggest that subchronic
exposure to TCDD, PeCDF, and PCB126
has an extensive impact on global hepatic
gene expression that involves many genes.
Furthermore, it is important to note that the
expression or repression of the genes exam-
ined may result from direct regulation by
the AhR, events further downstream from a
direct regulation of some gene by the AhR,
and/or a response to the tissue injury result-
ing from the genes directly or indirectly
regulated by the dioxin-like chemicals via
the AhR.
PCB153 is the most prevalent PCB
congener in biologic tissues (Kimbrough
1995; Krogaenas et al. 1998; Safe 1994). It
is also extraordinarily persistent and its
half-life may exceed 100 years in marine
sediments (Jonsson et al. 2003). PCB153
exposure has been associated with various
biologic effects including developmental
toxicity (Kuchenhoff et al. 1999) and
induction of CYP2B1 and other phenobar-
bital-responsive genes (Connor et al.
1995). Although PCB153 does not bind to
AhR and produced minimal hepatic hyper-
trophy after 13 weeks of subchronic expo-
sure, PCB153 did promote differential
expression of several biomarker genes for
liver injury (Figure 3). Thus, gene expres-
sion profiling may be a more sensitive
Toxicogenomics | Vezina et al.
1640 VOLUME 112 | NUMBER 16 | November 2004 • Environmental Health Perspectives
A B
Figure 3. Hepatic genes differentially expressed during PCB153 exposure but not during exposure to
PCDD, PeCDF, PCB126. Acc. no., GenBank accession number. PTM was used to identify differentially
expressed genes in livers of rats exposed to PCB153 compared with rats exposed to AhR ligands.
Matching genes conformed to a template where the relative expression ratios for toxicant versus vehicle
exposure were TCDD = 0, PeCDF = 0, PCB126 = 0, and PCB153 = 1 (r2 = 0.9). The PTM output was further
reﬁned to include only those genes differentially expressed ≥ 2-fold in livers of rats exposed to PCB153
compared with vehicle control animals. (A) PTM diagram showing genes differentially expressed during
PCB153 exposure. The color key indicates the magnitude of change. (B) Average fold changes for n =3
Affymetrix GeneChips (each chip represents pooled RNA from two animals). Accession numbers and
gene names are from GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide).gauge of PCB153 toxicity than standard his-
tology, and this hypothesis will be tested
with low-dose PCB153 exposures in future
experiments. PCB153 activates an acquired
immune response in mice (Smialowicz et al.
1997). PCB153 exposure in this study was
associated with differential gene expression
of proinflammatory cytokines, including
IL1, IL2, and the immune response gene
MX1. PCB153 exposure decreased expres-
sion of the apoptotic genes BCL-2 and
WEE1. BCL-2 and WEE1 are responsive to
p53 and are down-regulated during apopto-
sis (Bishay et al. 2000; Leach et al. 1998).
PCB153 exposure selectively enhanced
expression of cAMP response element
modulator (CREM) protein. CREM gene
activation is a signature response to liver
regeneration after hepatocyte injury. CREM
mRNA is increased after partial hepatec-
tomy in wild-type mice and liver regenera-
tion is inhibited in CREM(–/–) mice (Servillo
et al. 1998). The identiﬁcation of these and
other PCB153-responsive genes in the pre-
sent study provides new targets for future
mechanistic studies of PCB153 toxicity.
The mutual AhR binding affinity of
TCDD, PeCDF, and PCB126 is likely
responsible for strong similarity between
global gene expression profiles produced
by these chemicals. However, PCA also
revealed that gene expression proﬁles asso-
ciated with PCB126 and PeCDF exposures
were more closely related to each other
than to TCDD. On the basis of this ﬁnd-
ing, it is possible that PeCDF and PCB126
activate a unique group of genes not acti-
vated during TCDD exposure.
We identiﬁed a limited subset of genes
activated by PeCDF and PCB126 but not
TCDD (Figure 4). Induction of CAT,
cytochrome b5 (CYB5), and COX oxidata-
tive stress response genes (Poulsen et al.
2000) suggests that PeCDF and PCB126
exposures are capable of inducing oxidative
stress. PeCDF and PCB126 also induced
growth arrest and DNA-damage-inducible
45 (Gadd45) expression, a DNA-damage–
inducible gene product (Sheikh et al.
2000). Induction of Gadd45 during PeCDF
and PCB126 exposures may indicate oxida-
tive DNA damage in liver from animals
exposed to these toxicants. Oxidative stress
was previously reported during AhR activa-
tion (Dalton et al. 2002). Interestingly,
however, oxidative stress response genes
were not activated in livers from animals
exposed to TCDD in the present study. It
is interesting that PeCDF produced less
hypertrophy than did TCDD, yet was
more effective in activating the expression
of oxidative stress response genes. These
data may indicate that PeCDF and
PCB126 exposures promote oxidative stress
through a unique, AhR-independent mech-
anism and/or that the responses are sec-
ondary to liver injury produced during the
subchronic exposure.
AhR activation plays a critical role in
many end points of TCDD toxicity
[Agency for Toxic Substances and Disease
Registry (ATSDR) 1998; Hahn 2002;
Mimura and Fujii-Kuriyama 2003; Van
den Berg et al. 1998]. PCA from the pre-
sent study suggests that subchronic expo-
sure to AhR ligands causes differential
expression of numerous genes. Although a
few AhR target genes have been identified
in previous studies, many members of the
AhR gene battery remain unknown.
Genomic and proteomic approaches pro-
vide valuable opportunities to elucidate
additional genes involved in AhR signal
transduction and hepatotoxic responses to
dioxin-like chemicals.
PTM revealed genes specifically
induced or repressed by AhR ligands
TCDD, PeCDF, and PCB126 but not by
PCB153 (Figure 5). Many of these genes
were previously classified as being dioxin
responsive, which validated the efficacy of
the PTM approach and further verified
RNA sample integrity. PTM also revealed
several genes, including C-CAM4, CAP2,
SERPIN7A, CES3, and expressed sequence
tags (ESTs) not yet associated with the
AhR signaling pathway (Table 3).
C-CAM4 represents a novel dioxin-
responsive gene. In the present study,
C-CAM4 was selectively induced in rats
exposed to AhR ligands, but not in rats
exposed to PCB153, and was among the
genes most highly up-regulated by TCDD
exposure (Table 3, Figure 5). C-CAM4
does not contain a promoter-based DRE
sequence, which suggests that it may not be
regulated directly by AhR.
C-CAM4 is a recent addition to the
carcinoembryonic antigen (CEA) family of
cell adhesion molecules (Earley et al.
1996). CEA immunoglobulins demon-
strate important roles in growth and differ-
entiation. Although most soluble CEA
molecules are unable to mediate intercellu-
lar associations, C-CAM4 actively pro-
motes cell adhesion (Lin et al. 1998).
C-CAM1 is a secretory paralog of
C-CAM4, is expressed during hepatocyte
differentiation (Cheung et al. 1993;
Thompson et al. 1993), and is selectively
down-regulated in hepatocellular carci-
noma (Cheung et al. 1993; Thompson
et al. 1993). TCDD has been associated
with hepatocellular carcinoma in female
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Figure 4. Hepatic genes activated or repressed during PeCDF and PCB126 exposure but not during TCDD
exposure. PTM was used to identify genes co-expressed after exposure to PeCDF and PCB126 but not TCDD
for 13 weeks. Acc. no., GenBank accession number. Matching genes conformed to a template where the
relative expression ratios for toxicant versus vehicle exposure were TCDD = 0.2, PeCDF = 1, and PCB126 = 1
(r2 = 0.9). The PTM output was further reﬁned to include only those genes differentially expressed ≥ 2-fold in
livers of rats exposed to PeCDF and PCB126 compared with vehicle control animals. (A) PTM diagram show-
ing co-expressed genes. The color key indicates the magnitude of change. (B) Average fold changes for n =
3 Affymetrix GeneChips (each chip represents pooled RNA from two animals). Accession numbers and gene
names are from GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide)Spartan SD rats (Kociba et al. 1978) and
with hepatocellular adenoma and cholan-
giocarcinoma in a recent NTP study of
female Harlan SD rats (NTP 2004a). The
NTP study also found evidence of other
hepatotoxic responses after 2 years of
chronic exposure to TCDD, including
hepatocyte hypertrophy, multinucleated
hepatocyte, diffuse fatty change, bile duct
hyperplasia, bile duct cyst, oval cell hyper-
plasia, necrosis, pigmentation, inflamma-
tion, nodular hyperplasia, portal fibrosis,
cholangiofibrosis, and toxic hepatopathy
(NTP 2004a). No major evidence for
hepatotoxicity was observed after 13 weeks
of exposure to TCDD, but livers from
female rats exposed for this time period
were hypertrophic. The increased expres-
sion of secreted C-CAM4 in these rats may
suggests that TCDD initiates a cellular
transition from membrane-bound C-CAM1
expression in normal tissue to secreted
C-CAM4 expression during hypertrophy
and neoplastic transformation. Although
C-CAM4 may be a potential marker for
disrupted cell differentiation in livers of
animals exposed to dioxin-like toxicants, it
will be important in future studies to inves-
tigate protein expression in conjunction
with gene expression
Like C-CAM4, CAP2 is a novel dioxin-
responsive gene that exhibits dynamic acti-
vation in the presence of AhR ligands
(Table 3, Figure 5). The CAP2 promoter is
also devoid of XRE sequences. CAP2
mRNA is expressed at moderate to low lev-
els in normal rat liver tissue (Swiston et al.
1995) but is markedly induced by TCDD
and related compounds. It is unclear
whether CAP2 activity is implicated in the
preneoplastic hepatotoxic effects of dioxin
in rats, but a yeast homolog of CAP2 asso-
ciates with the actin cytoskeleton (Lila and
Drubin 1997), is responsible for the post-
translational posttranslational processing of
Ras, and serves as an effector for Ras-
dependent activation of adenylyl cyclase
(Shima et al. 1997). Ras expression was
increased in altered hepatic foci from a
diethyl nitrosamine/TCDD tumor initia-
tion and promotion study (Sills et al.
1994). A Ras-related mechanism sup-
pressed CYP1A1 expression, potentially
serving as a negative feedback mechanism
that rectiﬁes CYP1A1 levels in the presence
of TCDD (Reiners et al. 1997). Although
the AhR pathway may indeed have cross
talk with the adenylyl cyclase pathway, the
specific details of these interactions are
unclear. CAP2 may play an important role
in this signaling cross talk and warrants
further characterization. As with C-CAM4,
future studies will investigate protein
expression in conjunction with the expres-
sion of this gene.
This study represents one of the first
attempts to characterize hepatic gene
expression in the context of subchronic
exposure to carcinogenic doses of dioxin-
like chemicals. DNA microarrays and/or
RT-PCR successfully identified novel
dioxin-responsive genes that were either up-
or down-regulated after exposure to AhR
ligands (TCDD, PeCDF, PCB126) but not
after exposure to the non-AhR ligand
PCB153. Future studies are needed to
assess the species- and tissue-speciﬁc expres-
sion of these genes and their respective
functional proteins to establish whether
these differentially expressed genes may be a
response to and/or lead to the carcinogenic
and/or noncarcinogenic effects of these
compounds in humans and laboratory ani-
mals. Together, these ﬁndings may help to
elucidate some of the fundamental features
of dioxin toxicity and may further clarify
the biologic role of the enigmatic AhR
signaling pathway.
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Figure 5. Identiﬁcation of novel dioxin-responsive genes. Gene expression data were clustered by PTM to
identify co-expressed genes in livers of rats exposed to AhR ligands TCDD, PeCDF, and PCB126 for 13 weeks.
Acc. no., GenBank accession number. Matching genes conformed to a template where the relative expression
ratios for toxicant versus vehicle exposure were TCDD = 0.8, PeCDF = 0.8, PCB126 = 0.8, and PCB153 = 0.1
(R2= 0.9). Each row represents a separate gene; each column speciﬁes the toxicant treatment (n= 3 replicate
arrays per toxicant). The PTM output was further refined to include only genes differentially expressed
≥ 2-fold in livers of rats exposed to PeCDF and PCB126 compared with control animals. The color key indi-
cates the magnitude of change. Italicized genes were previously shown to respond to dioxin. Accession num-
bers and gene names are from GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide).REFERENCES
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